The Type I Interferonopathies
- PMID: 27813875
- DOI: 10.1146/annurev-med-050715-104506
The Type I Interferonopathies
Abstract
Type I interferons (IFNs) play a central role in the immune defense against viral infections. Type I IFN activation is induced by pattern-recognition receptors of the innate immune system that sense pathogen-derived nucleic acids. Cellular responses to type I IFN signaling are orchestrated by a complex network of regulatory pathways that involve both the innate and adaptive immune system. The genetic and molecular dissection of rare Mendelian disorders associated with constitutive overproduction of type I IFN has provided unique insight into cell-intrinsic disease mechanisms that initiate and sustain autoinflammation and autoimmunity and that are caused by disturbances in the intracellular nucleic acid metabolism or in cytosolic nucleic acid-sensing pathways. Collectively, these findings have greatly advanced our understanding of mechanisms that protect the organism against inappropriate immune activation triggered by self nucleic acids while maintaining a prompt and efficient immune response to foreign nucleic acids derived from invading pathogens.
Keywords: autoimmunity; autoinflammation; innate immunity; nucleic acid metabolism; nucleic acid sensing; type I interferon.
Similar articles
-
Intracellular Nucleic Acid Detection in Autoimmunity.Annu Rev Immunol. 2017 Apr 26;35:313-336. doi: 10.1146/annurev-immunol-051116-052331. Epub 2017 Jan 30. Annu Rev Immunol. 2017. PMID: 28142323 Free PMC article. Review.
-
Type I interferon-mediated autoinflammation and autoimmunity.Curr Opin Immunol. 2017 Dec;49:96-102. doi: 10.1016/j.coi.2017.09.003. Epub 2017 Nov 10. Curr Opin Immunol. 2017. PMID: 29128691 Review.
-
Type I interferonopathies: a novel set of inborn errors of immunity.Ann N Y Acad Sci. 2011 Nov;1238:91-8. doi: 10.1111/j.1749-6632.2011.06220.x. Ann N Y Acad Sci. 2011. PMID: 22129056
-
Nucleic acid driven sterile inflammation.Clin Immunol. 2013 Jun;147(3):207-15. doi: 10.1016/j.clim.2013.01.003. Epub 2013 Jan 19. Clin Immunol. 2013. PMID: 23419883 Review.
-
Interferonopathies: From concept to clinical practice.Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101975. doi: 10.1016/j.berh.2024.101975. Epub 2024 Aug 8. Best Pract Res Clin Rheumatol. 2024. PMID: 39122631 Review.
Cited by
-
Aicardi-Goutières Syndrome Type 1: A Novel Missense Variant and Review of the Mutational Spectrum.Iran J Child Neurol. 2024 Summer;18(3):117-129. doi: 10.22037/ijcn.v18i3.43274. Epub 2024 Jun 22. Iran J Child Neurol. 2024. PMID: 38988838 Free PMC article.
-
The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9.Cells. 2019 Aug 17;8(8):919. doi: 10.3390/cells8080919. Cells. 2019. PMID: 31426476 Free PMC article.
-
Interferon-Stimulated Genes-Mediators of the Innate Immune Response during Canine Distemper Virus Infection.Int J Mol Sci. 2019 Apr 1;20(7):1620. doi: 10.3390/ijms20071620. Int J Mol Sci. 2019. PMID: 30939763 Free PMC article.
-
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.Ann Rheum Dis. 2022 May;81(5):601-613. doi: 10.1136/annrheumdis-2021-221814. Epub 2022 Jan 27. Ann Rheum Dis. 2022. PMID: 35086813 Free PMC article.
-
Congenital deficiency reveals critical role of ISG15 in skin homeostasis.J Clin Invest. 2022 Feb 1;132(3):e141573. doi: 10.1172/JCI141573. J Clin Invest. 2022. PMID: 34847081 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
